Curis stock company
WebApr 7, 2024 · As of April 06, 2024, Curis, Inc. had a $58.0 million market capitalization, putting it in the 28th percentile of companies in the Biotechnology & Medical Research … WebCuris in the past 3 months CRIS Stock 12 Months Forecast $7.00 (1047.54% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Curis in the last 3 months. The average price target is $7.00 with a high …
Curis stock company
Did you know?
WebQuickest stock price recoveries post dividend payment. This trading strategy invovles purchasing a stock just before the ex-dividend date in order to collect the dividend and … WebMar 31, 2024 · Curis ( NASDAQ:CRIS) and SAB Biotherapeutics ( NASDAQ:SABS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and …
WebApr 6, 2024 · LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on March 31, 2024, the independent Compensation Committee of the Board of Directors of Curis approved the grant of … WebCuris (CRIS) delivered earnings and revenue surprises of 14.29% and 4.72%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for …
WebApr 3, 2024 · Curis Stock Performance. Curis stock opened at $0.60 on Monday. The stock has a market cap of $57.59 million, a PE ratio of -0.98 and a beta of 2.88. Curis has a fifty-two week low of $0.47 and a ...
WebFind the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Web1 day ago · Click here to access A+ stock grades COMPANY SUMMARY Curis, Inc. is a biotechnology company. The Company is focused on the development of therapeutics for the treatment of cancer. Its clinical stage drug candidates are Emavusertib and CI-8993. bluecowcarwash.comWebCuris, Inc. (CRIS) Stock Price & News - Google Finance Home CRIS • NASDAQ Curis, Inc. Follow Share $0.60 Apr 5, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Bird Global... blue cowboy hat hard hatWebApr 5, 2024 · Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, including its lead development... blue cowboy hat for womenWebJan 13, 2024 · About Curis, Inc. 128 SPRING STREET BUILDING C - SUITE 500, LEXINGTON, Massachusetts, 2421, United States +1 617 503-6500 … free iphone if you switchWebJun 11, 2024 · Jun. 11, 2024, 09:56 AM. Curis Inc (NASDAQ:CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid … blue cow car wash hoursWebApr 9, 2024 · Curis stock last closed at $0.65, up 6.39% from the previous day, and has decreased 50.83% in one year. It has underperformed other stocks in the Biotechnology … free iphone gps trackerWebApr 3, 2024 · The company had revenue of $2.89 million for the quarter, compared to analyst estimates of $3.03 million. Curis had a negative net margin of 557.68% and a … blue cow cheese company